Literature DB >> 17587580

Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).

Olga Koop1, Anja Schirmacher, Eva Nelis, Vincent Timmerman, Peter De Jonghe, Bernd Ringelstein, Vedrana Milic Rasic, Philippe Evrard, Jutta Gärtner, Kristl G Claeys, Silke Appenzeller, Bernd Rautenstrauss, Kathrin Hühne, Maria A Ramos-Arroyo, Helmut Wörle, Jukka S Moilanen, Simon Hammans, Gregor Kuhlenbäumer.   

Abstract

Giant axonal neuropathy (GAN, MIM: 256850) is a devastating autosomal recessive disorder characterized by an early onset severe peripheral neuropathy, varying central nervous system involvement and strikingly frizzly hair. Giant axonal neuropathy is usually caused by mutations in the gigaxonin gene (GAN) but genetic heterogeneity has been demonstrated for a milder variant of this disease. Here, we report ten patients referred to us for molecular genetic diagnosis. All patients had typical clinical signs suggestive of giant axonal neuropathy. In seven affected individuals, we found disease causing mutations in the gigaxonin gene affecting both alleles: two splice-site and four missense mutations, not reported previously. Gigaxonin binds N-terminally to ubiquitin activating enzyme E1 and C-terminally to various microtubule associated proteins causing their ubiquitin mediated degradation. It was shown for a number of gigaxonin mutations that they impede this process leading to accumulation of microtubule associated proteins and there by impairing cellular functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587580     DOI: 10.1016/j.nmd.2007.03.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

Review 1.  Two novel mutations in the GAN gene causing giant axonal neuropathy.

Authors:  Monica Irad Normendez-Martínez; Lucero Monterde-Cruz; Roberto Martínez; Magdalena Marquez-Harper; Nayelli Esquitin-Garduño; Margarita Valdes-Flores; Leonora Casas-Avila; Valeria Ponce de Leon-Suarez; Viktor Javier Romero-Díaz; Alberto Hidalgo-Bravo
Journal:  World J Pediatr       Date:  2018-06-06       Impact factor: 2.764

2.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

Review 3.  A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Authors:  James J Kang; Isabelle Y Liu; Marilene B Wang; Eri S Srivatsan
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

4.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

5.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

6.  Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel.

Authors:  Sharon Aharoni; Katy E S Barwick; Rachel Straussberg; Gaurav V Harlalka; Yoram Nevo; Barry A Chioza; Meriel M McEntagart; Aviva Mimouni-Bloch; Michael Weedon; Andrew H Crosby
Journal:  BMC Med Genet       Date:  2016-11-16       Impact factor: 2.103

7.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

8.  Giant Axonal Neuropathy with Unusual Neuroimagings Caused by Compound Heterozygous Mutations in GAN Gene.

Authors:  Shuang Cai; Jie Lin; Yi-Qi Liu; Jia-Hong Lu; Chong-Bo Zhao
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.